Oric Pharmaceuticals Inc (ORIC)
Oric Pharmaceuticals stock today
Oric Pharmaceuticals closed at $9.24 on October 30, 2026, up 2.78% on the day. Over the past year it returned -30.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $957 million.
| Period | ORIC | S&P 500 (SPY) |
|---|---|---|
| 1 month | -31.4% | -0.9% |
| 3 months | -20.6% | +2.1% |
| Year to date | +13.0% | +11.7% |
| 1 year | -30.7% | +12.4% |
| 3 years | +45.1% | +88.5% |
| 5 years | -36.9% | +76.0% |
Key statistics
- Market value
- $957M
- 52-week range
- $7.47 to $14.65
- Next report
- Nov 12, 2026 (estimated)
About Oric Pharmaceuticals
Biopharmaceutical company developing precision medicines for rare and common cancers.
Sector: Health Care
More on Oric Pharmaceuticals
- Returns: what $1,000 became$1,000 five years ago is $631.15 today
No forecast, no recommendation. This page describes Oric Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.